AustLII Home | Databases | WorldLII | Search | Feedback

Edited Legal Collections Data

You are here:  AustLII >> Databases >> Edited Legal Collections Data >> 2011 >> [2011] ELECD 950

Database Search | Name Search | Recent Articles | Noteup | LawCite | Help

"Contents" [2011] ELECD 950; in Shadlen, C. Kenneth; Guennif, Samira; Guzmán , Alenka; Lalitha, N. (eds), "Intellectual Property, Pharmaceuticals and Public Health" (Edward Elgar Publishing, 2011)

Book Title: Intellectual Property, Pharmaceuticals and Public Health

Editor(s): Shadlen, C. Kenneth; Guennif, Samira; Guzmán , Alenka; Lalitha, N.

Publisher: Edward Elgar Publishing

ISBN (hard cover): 9781849800143

Section Title: Contents

Number of pages: 2

Extract:

Contents
List of contributors vii
Acknowledgements xi

1. Globalization, intellectual property rights, and
pharmaceuticals: meeting the challenges to addressing health
gaps in the new international environment 1
Kenneth C. Shadlen, Samira Guennif, Alenka Guzmán and
N. Lalitha
2. Pharmaceutical production and access to essential medicines
in South Africa 29
Heinz Klug
3. Intellectual property and access to medicines: paradoxes in
Moroccan policy 56
Gaëlle Krikorian
4. The invisible threat: trade, intellectual property, and
pharmaceutical regulations in Colombia 77
Tatiana Andia
5. The challenges of constructing pharmaceutical capabilities
and promoting access to medicines in Mexico under TRIPS 110
Alenka Guzmán
6. Corporate power and state resistance: Brazil's use of TRIPS
flexibilities for its National AIDS Program 149
Matthew Flynn
7. The politics of patents and drugs in Brazil and Mexico: the
industrial bases of health policies 178
Kenneth C. Shadlen
8. Pharmaceutical patent policy in developing countries:
learning from the Canadian experience 202
Jean-Frédéric Morin and Mélanie Bourassa Forcier
9. Access to Indian generic drugs: emerging issues 225
N. Lalitha
10. Sufficient but expensive drugs: a double-track system that
facilitated supply capability in China 253
Mariko Watanabe and Luwen Shi


v
vi Intellectual property, pharmaceuticals and public health

11. Access to essential drugs in Thailand: intellectual property
rights and other institutional matters affecting public health
in a developing country 286
Samira Guennif
12. The TRIPS agreement and health innovation in Bangladesh 310
Padmashree Gehl Sampath

Index 325


AustLII: Copyright Policy | Disclaimers | Privacy Policy | Feedback
URL: http://www.austlii.edu.au/au/journals/ELECD/2011/950.html